Armata Pharmaceuticals, Inc. (ARMP) SEC Filings

Financials(117)

Expand

Events(324)

Expand

8-KOther Events23 Sep
8-KRegulation FD Disclosure14 Sep
8-K June 30, 2026 December 31, 2025 AssetsCurrent assetsCash and cash equivalents$23,952$8,688Prepaid expenses and other current assets6731,508Other receivables2,532472Total current assets27,15710,668Property and equipment, net11,23012,194Operating lease right-of-use asset32,88433,911Intangible assets, net13,74613,746Other long-term assets4,9336,363Total assets$89,950$76,882Liabilities and stockholders’ deficitAccounts payable, accrued and other current liabilities$8,715$8,947Convertible Loan, current163,904—Term debt, current77,580—Total current liabilities250,1998,947Convertible Loan, non-current—153,860Term debt, non-current42,024103,061Operating lease liabilities, net of current portion25,82326,533Deferred tax liability3,0773,077Total liabilities321,123295,478Total stockholders’ deficit(231,173)(218,596)Total liabilities and stockholders’ deficit$89,950$76,88212 Aug
8-KRegulation FD Disclosure20 Jul
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers20 Jul
8-KRegulation FD Disclosure13 Jul
8-K/ADeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers24 Jun
8-KOther Events23 Jun
8-KSubmission of Matters to a Vote of Security Holders16 Jun
8-K March 31, 2026 December 31, 2025 AssetsCurrent assetsCash and cash equivalents$4,754$8,688Prepaid expenses and other current assets1,1451,508Other receivables47472Total current assets5,94610,668Property and equipment, net11,78012,194Operating lease right-of-use asset33,39533,911Intangible assets, net13,74613,746Other long term assets4,9336,363Total assets$69,800$76,882Liabilities and stockholders’ deficitAccounts payable, accrued and other current liabilities$9,228$8,947Total current liabilities9,2288,947Convertible loan, non-current254,922153,860Term debt, non-current87,976103,061Operating lease liabilities, net of current portion26,18326,533Deferred tax liability3,0773,077Total liabilities381,386295,478Total stockholders’ deficit(311,586)(218,596)Total liabilities and stockholders’ deficit$69,800$76,88213 May
8-KRegulation FD Disclosure7 May
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers27 Apr
8-KOther Events2 Apr
8-K December 31, 2025 December 31, 2024 AssetsCurrent assetsCash and cash equivalents$8,688$9,291Prepaid expenses and other current assets1,5081,273Other receivables472744Total current assets10,66811,308Property and equipment, net12,19413,241Operating lease right-of-use asset33,91141,687Intangible assets, net13,74613,746Other long term assets6,3636,455Total assets$76,882$86,437Liabilities and stockholders’ deficitAccounts payable, accrued and other current liabilities$8,947$9,295Term debt, current—38,954Total current liabilities8,94748,249Convertible loan, non-current153,86032,897Term debt, non-current103,06122,539Operating lease liabilities, net of current portion26,53327,694Deferred tax liability3,0773,077Total liabilities295,478134,456Total stockholders’ deficit(218,596)(48,019)Total liabilities and stockholders’ deficit$76,882$86,43725 Mar
8-KRegulation FD Disclosure19 Mar

Armata Pharmaceuticals, Inc.(ARMP US)

Armata Pharmaceuticals, Inc.(ARMP US)

Armata Pharmaceuticals, Inc.(ARMP US)

Armata Pharmaceuticals, Inc.(ARMP US)

SEC Filings

Financials(117)

Events(324)

Insider Ownership(267)

Beneficial Ownership(100)

Proxies(75)

Registrations(155)

Filing Review Correspondence(24)

SEC Orders And Notices(34)

Tender Offers And Going Private(2)

Exempt Offerings(6)

Other(9)

SEC Filings

Financials(117)

Events(324)

Insider Ownership(267)

Beneficial Ownership(100)

Proxies(75)

Registrations(155)

Filing Review Correspondence(24)

SEC Orders And Notices(34)

Tender Offers And Going Private(2)

Exempt Offerings(6)

Other(9)

Financials(117)

Events(324)

Insider Ownership(267)

Beneficial Ownership(100)

Proxies(75)

Registrations(155)

Filing Review Correspondence(24)

SEC Orders And Notices(34)

Tender Offers And Going Private(2)

Exempt Offerings(6)

Other(9)

Financials(117)

Events(324)

Insider Ownership(267)

Beneficial Ownership(100)

Proxies(75)

Registrations(155)

Filing Review Correspondence(24)

SEC Orders And Notices(34)

Tender Offers And Going Private(2)

Exempt Offerings(6)

Other(9)